Art

J-GLOBAL ID：200902251820201331   Reference number：09A0500308

ネフローゼ症候群:診断と治療の進歩 I.基礎と病態 1.定義・診断・病態

Author (1)： MITARAI TETSUYA (埼玉医大 総合医療セ 腎高血圧内科)
Material： 日本内科学会雑誌  (Journal of the Japanese Society of Internal Medicine)
Volume： 98  Issue： 5  Page： 984-992  Publication year： May. 10, 2009 
JST Material Number： F0916A  ISSN： 0021-5384  CODEN： NNGAA  Document type： Article
Article type： 解説  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： *Nephrotic Syndrome ,...
Semi thesaurus term： clinical condition ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=09A0500308&from=J-GLOBAL&jstjournalNo=F0916A") }}

JST classification (1)： Clinical medicine on urogenital system in general  (GM01030E)

Reference (10)：

• VARGHESE, SA. Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol. 2007, 18, 3, 913-922
• SAVIN, VJ. Permeability factors in focal segmental glomerulosclerosis. Semin Nephrol. 2003, 232, 147-160
• PUDUR, S. Albumin permeability (Palb) in focal segmental glomeruroscrelosis (FSGS) is associated with rapid progression to end-stage renal disease (ESRD). Am J Kidney Dis. 2006, 47, B1-B18
• HARVEY, SJ. Disruption of glomerular basement membrane charge through podocyte-specific mutation of agrin does not alter glomerular permselectivity. Am J Pathol. 2007, 171, 139-152
• KAWACHI, H. Role of podocyte slit diaphragm as a filtration barrier. Nephrology (Carlton). 2006, 11, 4, 274-281

Terms in the title (6)： ネフローゼ症候群 ,  診断 ,  治療 ,  基礎 ,  病態 ,  定義